Jonathan Silverstein - Profile and Investment Details

Investor Profile

Jonathan Silverstein is a Private Equity Firm based in New York City, New York, United States with a diverse investment portfolio that includes companies such as Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics, Olema Oncology, Aerin Medical, CoreMap, NewMed Medical, BioShin, Scribe Therapeutics, X4 Pharmaceuticals, Visen Pharmaceuticals, Abbisko Therapeutics, Sonendo, Cullinan Oncology, Silverback Therapeutics, Harbour Biomed, Nuvation Bio, Century Therapeutics, GentiBio, Decibel Therapeutics, Cytek Biosciences, Caris Life Sciences, UNUM TherapeuticsScorpion Therapeutics, Crossover Health, PMV Pharmaceuticals, Immvira, Verona Pharma, Adagio Therapeutics, Zhaoke Ophthalmology Pharmaceutical, Pandion Therapeutics, Adimab, Cleave Therapeutics, Adicet Bio, BlossomHill Therapeutics, Ikena Oncology, AbCellera Biologics, Nucleix, Aspen Neuroscience, VectivBio, GrayBug, ReViral, Harmony Biosciences, Graphite Bio, RayzeBio, Erasca, MobileODT, Terns Pharmaceuticals, Repare Therapeutics, AnchorDx, Ventyx Biosciences, Clover Biopharmaceuticals, Protekt Therapeutics, Nuohui Health, I-Mab Biopharma, InventisBio, Prelude Therapeutics, Gracell Biotechnologies, Ruipeng Pet Healthcare, Janux Therapeutics, ImmPACT Bio USA, ORIC Pharmaceuticals, MBX Biosciences, Enliven Therapeutics, Acutus Medical, Foamix, Miaoshou Doctor, Delfi Diagnostics, Rongchang Pharmaceutical, Remegen, Noctrix Health, MabPlex International, Passage Bio, Chinook Therapeutics, Keros Therapeutics, Alizé Pharma, Chemomab, MDClone, Fore Biotherapeutics, VelosBio, Achilles Therapeutics, Galecto, NeuroPace, Kinnate Biopharma, Q32 Bio, Azura Ophthalmics, ReCode Therapeutics, TytoCare, ESCAPE Bio, Arcutis Biotherapeutics, . Over time, Jonathan Silverstein has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Jonathan Silverstein is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wellness, Life Science, Engineering, Education, Information Technology (IT), Mobile, Biotechnology, Drug Development, Clinical Trials, Research, Personalized Medicine, Health Diagnostics, Travel, Medical, B2B, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with Jonathan Silverstein, as their portfolio suggests a familiarity and interest in this area.

Understanding Jonathan Silverstein’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.